Tonix Pharmaceuticals Holding (TNXP) Short term Debt (2011 - 2024)
Tonix Pharmaceuticals Holding (TNXP) posted Short term Debt of $2.8 million for Q4 2024, little changed on a QoQ basis from $2.8 million in Q3 2024, and up 20.0% year-over-year from $2.4 million in Q1 2024.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Short term Debt (2011 - 2024) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Short term Debt for 3 years, with the latest figure at $2.8 million in Q4 2024.
- On a quarterly basis, Short term Debt rose 20.0% year-over-year to $2.8 million in Q4 2024; TTM through Dec 2024 was $2.8 million, a 20.0% increase from a year earlier, with the FY2024 full-year figure at $2.8 million, up 20.0% from the prior year.
- Short term Debt was $2.8 million for Q4 2024 at Tonix Pharmaceuticals Holding, roughly flat from $2.8 million in the prior quarter.
- The five-year high for Short term Debt was $2.8 million in Q1 2024, with the low at $2.4 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 2.82 Mn |
| Dec 31, 2023 | 2.35 Mn |
| Dec 31, 2011 | 150,000.00 |
| Sep 30, 2011 | 10,000.00 |